3zpo
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of JmjC domain of human histone demethylase UTY with bound GSK J1== | ==Crystal structure of JmjC domain of human histone demethylase UTY with bound GSK J1== | ||
- | <StructureSection load='3zpo' size='340' side='right' caption='[[3zpo]], [[Resolution|resolution]] 2.00Å' scene=''> | + | <StructureSection load='3zpo' size='340' side='right'caption='[[3zpo]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3zpo]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3zpo]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ZPO OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ZPO FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FE2:FE+(II)+ION'>FE2</scene>, <scene name='pdbligand=K0I:3-[[2-PYRIDIN-2-YL-6-(1,2,4,5-TETRAHYDRO-3-BENZAZEPIN-3-YL)PYRIMIDIN-4-YL]AMINO]PROPANOIC+ACID'>K0I</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FE2:FE+(II)+ION'>FE2</scene>, <scene name='pdbligand=K0I:3-[[2-PYRIDIN-2-YL-6-(1,2,4,5-TETRAHYDRO-3-BENZAZEPIN-3-YL)PYRIMIDIN-4-YL]AMINO]PROPANOIC+ACID'>K0I</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3zpo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3zpo OCA], [https://pdbe.org/3zpo PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3zpo RCSB], [https://www.ebi.ac.uk/pdbsum/3zpo PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3zpo ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/UTY_HUMAN UTY_HUMAN] Histone demethylase (By similarity). |
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The Jumonji C lysine demethylases (KDMs) are 2-oxoglutarate- and Fe(II)-dependent oxygenases. KDM6A (UTX) and KDM6B (JMJD3) are KDM6 subfamily members that catalyze demethylation of N()-methylated histone 3 lysine 27 (H3K27), a mark important for transcriptional repression. Despite reports stating that UTY(KDM6C) is inactive as a KDM, we demonstrate by biochemical studies, employing MS and NMR, that UTY(KDM6C) is an active KDM. Crystallographic analyses reveal that the UTY(KDM6C) active site is highly conserved with those of KDM6B and KDM6A. UTY(KDM6C) catalyzes demethylation of H3K27 peptides in vitro, analogously to KDM6B and KDM6A, but with reduced activity, due to point substitutions involved in substrate binding. The results expand the set of human KDMs and will be of use in developing selective KDM inhibitors. | ||
+ | |||
+ | Human UTY(KDM6C) is a male-specific N-methyl lysyl demethylase.,Walport LJ, Hopkinson RJ, Vollmar M, Madden SK, Gileadi C, Oppermann U, Schofield CJ, Johansson C J Biol Chem. 2014 Jun 27;289(26):18302-13. doi: 10.1074/jbc.M114.555052. Epub, 2014 May 5. PMID:24798337<ref>PMID:24798337</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 3zpo" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Arrowsmith CH]] |
- | [[Category: | + | [[Category: Bountra C]] |
- | [[Category: Edwards | + | [[Category: Edwards A]] |
- | [[Category: Gileadi | + | [[Category: Gileadi C]] |
- | [[Category: Goubin | + | [[Category: Goubin S]] |
- | [[Category: Johansson | + | [[Category: Johansson C]] |
- | [[Category: Krojer | + | [[Category: Krojer T]] |
- | [[Category: Oppermann | + | [[Category: Oppermann U]] |
- | [[Category: Shrestha | + | [[Category: Shrestha L]] |
- | [[Category: Vollmar | + | [[Category: Vollmar M]] |
- | [[Category: | + | [[Category: Von Delft F]] |
Current revision
Crystal structure of JmjC domain of human histone demethylase UTY with bound GSK J1
|
Categories: Homo sapiens | Large Structures | Arrowsmith CH | Bountra C | Edwards A | Gileadi C | Goubin S | Johansson C | Krojer T | Oppermann U | Shrestha L | Vollmar M | Von Delft F